
有关生物技术和 CRISPR 的最新论文和专利
This week: engineered exosomes, magnetic nanoparticles, therapeutic payload, CRISPR, TIGIT, CAR, NK cells, CRISPR/Cas9, gene editing, transmembrane receptors, inflammation treatment,
专利是政府授予发明人的一项合法权利,在规定期限内(通常为 20 年),发明人享有生产、使用和销售发明的专有权。这种保护鼓励创新,确保发明人可以从他们的创造中获得经济利益,而不必担心未经授权的复制。在产品设计和开发中,专利是保护知识产权、培养竞争优势、促进进一步研究和创新的重要工具。

This week: engineered exosomes, magnetic nanoparticles, therapeutic payload, CRISPR, TIGIT, CAR, NK cells, CRISPR/Cas9, gene editing, transmembrane receptors, inflammation treatment,

This week: Wearable device, COPD management, physiological parameters, sensor data, thermal recovery, ceramic oxygen concentrator, heat exchanger, electrochemical stack, inhaler

This week: frequency domain equalization, single-ended channels, Fast Fourier Transform, matrix inversion, communication method, DFT-s-OFDM, PUSCH transmission, MCS table, Predictive

2022 年,全世界共颁发了 350 万项专利。由此可见,知识产权对于
只有注册会员才能免费获得 100% 的全尺寸图片和下载。.
> 登录 <